HSPA13

gene
On this page

Summary

HSPA13 (heat shock protein family A (Hsp70) member 13, HGNC:11375) is a protein-coding gene on chromosome 21q11.2, encoding Heat shock 70 kDa protein 13 (P48723). Has peptide-independent ATPase activity. It is a selective cancer dependency (DepMap: 12.7% of cell lines).

The protein encoded by this gene is a member of the heat shock protein 70 family and is found associated with microsomes. Members of this protein family play a role in the processing of cytosolic and secretory proteins, as well as in the removal of denatured or incorrectly-folded proteins. The encoded protein contains an ATPase domain and has been shown to associate with a ubiquitin-like protein.

Source: NCBI Gene 6782 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 68 total — 1 pathogenic
  • Cancer dependency (DepMap): dependent in 12.7% of screened cell lines
  • MANE Select transcript: NM_006948

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:11375
Approved symbolHSPA13
Nameheat shock protein family A (Hsp70) member 13
Location21q11.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000155304
Ensembl biotypeprotein_coding
OMIM601100
Entrez6782

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000285667, ENST00000478035, ENST00000903931, ENST00000903932

RefSeq mRNA: 1 — MANE Select: NM_006948 NM_006948

CCDS: CCDS13567

Canonical transcript exons

ENST00000285667 — 5 exons

ExonStartEnd
ENSE000010202261438309514383146
ENSE000010202311437819914378412
ENSE000012803911437111514374284
ENSE000035787431437565214375819
ENSE000036086791438120314381543

Expression profiles

Bgee: expression breadth ubiquitous, 294 present calls, max score 97.14.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.2381 / max 709.2069, expressed in 1806 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
18975837.14101806
1897590.04998
1897600.047215

Top tissues by expression

299 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305397.14gold quality
cartilage tissueUBERON:000241896.58gold quality
cortical plateUBERON:000534396.50gold quality
islet of LangerhansUBERON:000000695.87gold quality
ganglionic eminenceUBERON:000402395.80gold quality
adrenal tissueUBERON:001830395.31gold quality
endothelial cellCL:000011595.06gold quality
pigmented layer of retinaUBERON:000178294.44gold quality
corpus epididymisUBERON:000435994.44gold quality
retinaUBERON:000096694.41gold quality
type B pancreatic cellCL:000016993.82gold quality
embryoUBERON:000092293.65gold quality
caput epididymisUBERON:000435893.54gold quality
orbitofrontal cortexUBERON:000416793.07gold quality
cauda epididymisUBERON:000436092.85gold quality
Brodmann (1909) area 23UBERON:001355492.59gold quality
CA1 field of hippocampusUBERON:000388192.55gold quality
superior frontal gyrusUBERON:000266192.14gold quality
choroid plexus epitheliumUBERON:000391192.06gold quality
seminal vesicleUBERON:000099891.69gold quality
postcentral gyrusUBERON:000258191.68gold quality
superficial temporal arteryUBERON:000161491.66gold quality
entorhinal cortexUBERON:000272891.60gold quality
substantia nigra pars compactaUBERON:000196591.58gold quality
medial globus pallidusUBERON:000247791.49gold quality
stromal cell of endometriumCL:000225590.97gold quality
parietal lobeUBERON:000187290.79gold quality
globus pallidusUBERON:000187590.78gold quality
superior vestibular nucleusUBERON:000722790.78gold quality
heart right ventricleUBERON:000208090.71gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes16.58

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

133 targeting HSPA13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-8485100.0077.574731
HSA-MIR-5692A100.0074.406850
HSA-MIR-9-5P100.0072.282361
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3924100.0072.092394
HSA-MIR-428299.9975.366408
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-477599.9875.006394
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-569699.9872.364487
HSA-MIR-60799.9773.625593
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-570-3P99.9672.414910
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-651-3P99.9473.485177
HSA-MIR-101-3P99.9475.032230
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-381-3P99.9371.872854

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 12.7% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 7)

  • in the Japanese population, STCH might be a new candidate for conferring susceptibility to gastric cancer (PMID:16087163)
  • These results suggest that STCH has a role in cell survival via modulation of the TRAIL-mediated cell death pathway. (PMID:18793616)
  • An entirely novel path is revealed toward therapeutic intervention of tauopathies by inhibition of the previously untargeted ATPase activity of Hsp70. (PMID:19793966)
  • novel role of STCH in the regulation of pHi through site-specific interactions with NBCe1-B and NHE1 and subsequent modulation of membrane transporter expression. (PMID:23303189)
  • Hspa13 Promotes Plasma Cell Production and Antibody Secretion. (PMID:32547538)
  • Differential Effects of STCH and Stress-Inducible Hsp70 on the Stability and Maturation of NKCC2. (PMID:33672238)
  • Heat shock protein Hspa13 regulates endoplasmic reticulum and cytosolic proteostasis through modulation of protein translocation. (PMID:36244454)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriohspa13ENSDARG00000040984
mus_musculusHspa13ENSMUSG00000032932
rattus_norvegicusHspa13ENSRNOG00000060979
caenorhabditis_elegansWBGENE00006059

Paralogs (13): HSPA5 (ENSG00000044574), HSPA8 (ENSG00000109971), HSPA9 (ENSG00000113013), HSPH1 (ENSG00000120694), HSPA2 (ENSG00000126803), HYOU1 (ENSG00000149428), HSPA4L (ENSG00000164070), HSPA4 (ENSG00000170606), HSPA6 (ENSG00000173110), HSPA14 (ENSG00000187522), HSPA1B (ENSG00000204388), HSPA1A (ENSG00000204389), HSPA1L (ENSG00000204390)

Protein

Protein identifiers

Heat shock 70 kDa protein 13P48723 (reviewed: P48723)

Alternative names: Heat shock protein family A member 13, Microsomal stress-70 protein ATPase core, Stress-70 protein chaperone microsome-associated 60 kDa protein

All UniProt accessions (2): P48723, A0A140VK72

UniProt curated annotations — full annotation on UniProt →

Function. Has peptide-independent ATPase activity.

Subunit / interactions. Binds UBQLN2.

Subcellular location. Microsome. Endoplasmic reticulum.

Tissue specificity. Constitutively expressed in all tissues.

Similarity. Belongs to the heat shock protein 70 family.

RefSeq proteins (1): NP_008879* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013126Hsp_70_famFamily
IPR018181Heat_shock_70_CSConserved_site
IPR042048HSPA13Family
IPR043129ATPase_NBDHomologous_superfamily

Pfam: PF00012

UniProt features (5 total): signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P48723-F187.430.69

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-3371453Regulation of HSF1-mediated heat shock response

MSigDB gene sets: 191 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, MORF_MSH3, BROWNE_HCMV_INFECTION_8HR_UP, MORF_BRCA1, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, LANG_MYB_FAMILY_TARGETS, WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2, RIZKI_TUMOR_INVASIVENESS_3D_DN, MODULE_66, GOBP_PROTEIN_MATURATION, AAACCAC_MIR140, GOBP_PROTEIN_FOLDING, SCHLOSSER_SERUM_RESPONSE_DN, MORF_RAP1A

GO Biological Process (2): protein refolding (GO:0042026), protein folding (GO:0006457)

GO Molecular Function (7): ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), heat shock protein binding (GO:0031072), protein folding chaperone (GO:0044183), ATP-dependent protein folding chaperone (GO:0140662), nucleotide binding (GO:0000166), protein binding (GO:0005515)

GO Cellular Component (7): nucleus (GO:0005634), cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829), plasma membrane (GO:0005886), intracellular membrane-bounded organelle (GO:0043231), extracellular exosome (GO:0070062)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Cellular response to heat stress1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein folding2
ATP-dependent activity2
intracellular membrane-bounded organelle2
intracellular anatomical structure2
cellular anatomical structure2
cytoplasm2
cellular process1
protein maturation1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
ribonucleoside triphosphate phosphatase activity1
protein binding1
molecular_function1
protein folding chaperone1
nucleoside phosphate binding1
heterocyclic compound binding1
binding1
endomembrane system1
membrane1
cell periphery1
membrane-bounded organelle1
intracellular organelle1
extracellular vesicle1

Protein interactions and networks

STRING

3845 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HSPA13UBQLN2Q9UHD9984
HSPA13UBQLN4Q9NRR5827
HSPA13UBQLN1Q9UMX0812
HSPA13LIPIQ6XZB0750
HSPA13HSPA12AO43301744
HSPA13B0YIZ1B0YIZ1695
HSPA13HSPA12BQ96MM6690
HSPA13STIP1P31948674
HSPA13PLEKHG4Q58EX7547
HSPA13QKIQ96PU8542
HSPA13RBPMSQ93062515
HSPA13RBM17Q96I25511
HSPA13PQBP1O60828510
HSPA13HSP90B1P14625503
HSPA13ATXN1P54253497

IntAct

140 interactions, top by confidence:

ABTypeScore
HSPA13UBQLN1psi-mi:“MI:0915”(physical association)0.830
UBQLN1HSPA13psi-mi:“MI:0915”(physical association)0.830
SGTAHSPA13psi-mi:“MI:0915”(physical association)0.720
HSPA13SGTApsi-mi:“MI:0915”(physical association)0.720
HSPA13UBQLN1psi-mi:“MI:0915”(physical association)0.670
HSPA13SGTBpsi-mi:“MI:0915”(physical association)0.670
HSPA13UBQLN2psi-mi:“MI:0915”(physical association)0.670
FBXO6MAN2B1psi-mi:“MI:0914”(association)0.640
DKKL1DENND11psi-mi:“MI:0914”(association)0.640
HSPA13B4GALT5psi-mi:“MI:0915”(physical association)0.560
HSPA13CRYGApsi-mi:“MI:0915”(physical association)0.560
PRSS22PPM1Apsi-mi:“MI:0914”(association)0.560
HSPA13POLE4psi-mi:“MI:0915”(physical association)0.550
TNFB4GALT5psi-mi:“MI:0914”(association)0.530
TOR1AIP1TXNpsi-mi:“MI:0914”(association)0.530
CMA1MANBApsi-mi:“MI:0914”(association)0.530
FBXO2TMEM131Lpsi-mi:“MI:0914”(association)0.530
HSPA13BAG6psi-mi:“MI:0915”(physical association)0.370
HSPA13RMI1psi-mi:“MI:0915”(physical association)0.370
HSPA13SSR1psi-mi:“MI:0915”(physical association)0.370
TANKCNOT1psi-mi:“MI:0914”(association)0.350

BioGRID (154): HSPA13 (Two-hybrid), UBQLN1 (Two-hybrid), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), UBQLN1 (Two-hybrid), HSPA13 (Two-hybrid), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), B4GALT5 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Proximity Label-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS)

ESM2 similar proteins: A1AWL7, A3M561, A8GMI8, A8GR49, B0BWJ7, B0VD55, B0VNV8, B2HZI1, B7H3H4, B7I5P9, C3PMP2, C4K0Z7, D1J722, D4A2Z8, E9PU17, E9PX95, F4IM84, G7LCC3, O35162, O52960, O88967, O96566, P48723, P52914, P70106, P80595, P99502, Q05931, Q18411, Q1RJ70, Q2TBX4, Q3UW68, Q4UKL3, Q4V339, Q55154, Q5E780, Q5JTY5, Q5R8D9, Q5RIA9, Q5XI69

Diamond homologs: A0A509AJG0, A2Q0Z1, A5A8V7, F5HB71, G0SCU5, G3I8R9, J9VZ70, O35162, O59855, O73885, O97125, P02827, P06761, P07823, P08108, P08418, P09435, P0DMV8, P0DMV9, P0DMW0, P0DMW1, P10591, P10592, P11021, P11142, P11147, P14659, P17066, P17156, P17879, P19120, P19208, P19378, P20029, P20163, P22202, P27420, P29843, P29844, P34930

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 131 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane524.8×7e-04

GO biological processes:

GO termPartnersFoldFDR
ERAD pathway1116.1×9e-08

Disease & clinical

Clinical variants and AI predictions

ClinVar

68 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance55
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
625662GRCh37/hg19 21p11.1-q21.2(chr21:10944001-25730963)Pathogenic

SpliceAI

654 predictions. Top by Δscore:

VariantEffectΔscore
21:14375646:TCTTA:Tdonor_loss1.0000
21:14375647:CTTA:Cdonor_loss1.0000
21:14375648:TTACC:Tdonor_loss1.0000
21:14375649:TACCA:Tdonor_loss1.0000
21:14375650:A:ACdonor_gain1.0000
21:14375650:A:Tdonor_loss1.0000
21:14375651:C:CCdonor_gain1.0000
21:14375651:CCAGA:Cdonor_gain1.0000
21:14375677:C:Adonor_gain1.0000
21:14375680:T:TAdonor_gain1.0000
21:14375729:A:ACdonor_gain1.0000
21:14375815:CAGTC:Cacceptor_gain1.0000
21:14375817:GTC:Gacceptor_gain1.0000
21:14375817:GTCC:Gacceptor_loss1.0000
21:14375818:TC:Tacceptor_gain1.0000
21:14375818:TCCT:Tacceptor_loss1.0000
21:14375819:CC:Cacceptor_gain1.0000
21:14375820:C:CCacceptor_gain1.0000
21:14375828:T:TCacceptor_gain1.0000
21:14375832:T:Cacceptor_gain1.0000
21:14375832:T:TCacceptor_gain1.0000
21:14378193:TGTTA:Tdonor_loss1.0000
21:14378194:GTTAC:Gdonor_loss1.0000
21:14378195:TTA:Tdonor_loss1.0000
21:14378196:TAC:Tdonor_loss1.0000
21:14378197:A:ATdonor_loss1.0000
21:14378198:C:Tdonor_loss1.0000
21:14381199:TTA:Tdonor_loss1.0000
21:14381200:TA:Tdonor_loss1.0000
21:14381201:A:ACdonor_gain1.0000

AlphaMissense

3073 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
21:14381270:T:AK100I1.000
21:14381362:G:CS69R1.000
21:14381362:G:TS69R1.000
21:14381364:T:GS69R1.000
21:14373703:C:GA444P0.999
21:14373711:G:TA441D0.999
21:14373712:C:GA441P0.999
21:14373717:C:TG439E0.999
21:14373718:C:GG439R0.999
21:14373718:C:TG439R0.999
21:14373804:C:GR410P0.999
21:14373816:C:AG406V0.999
21:14373816:C:TG406E0.999
21:14373817:C:AG406W0.999
21:14373817:C:GG406R0.999
21:14373817:C:TG406R0.999
21:14374137:A:GL299P0.999
21:14374145:T:AK296N0.999
21:14374145:T:GK296N0.999
21:14374269:C:AG255V0.999
21:14374269:C:TG255E0.999
21:14374270:C:GG255R0.999
21:14374270:C:TG255R0.999
21:14375661:C:GA247P0.999
21:14375693:A:GL236P0.999
21:14375700:A:GS234P0.999
21:14375708:A:GL231P0.999
21:14375725:G:CD225E0.999
21:14375725:G:TD225E0.999
21:14375726:T:GD225A0.999

dbSNP variants (sampled 300 via entrez): RS1000206146 (21:14381057 G>A), RS1000726163 (21:14385113 C>CA), RS1001020582 (21:14373295 T>C), RS1001284093 (21:14379654 T>C), RS1001474415 (21:14372940 T>C), RS1001576630 (21:14374031 G>A), RS1001664002 (21:14380733 G>A), RS1002287917 (21:14378089 T>C), RS1002318712 (21:14374779 G>A), RS1002574135 (21:14385049 G>C), RS1002655197 (21:14378820 A>C,G), RS1002665126 (21:14379116 T>G), RS1002993100 (21:14372511 A>G), RS1003404258 (21:14376926 C>A), RS1003762574 (21:14377104 T>C)

Disease associations

OMIM: gene MIM:601100 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

75 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporineincreases expression4
bisphenol Aaffects expression, increases expression, decreases expression3
sodium arseniteaffects cotreatment, increases abundance, increases expression3
Air Pollutantsincreases expression, decreases expression, increases abundance3
Estradiolincreases expression3
Tetrachlorodibenzodioxindecreases expression, affects expression3
mono-(2-ethylhexyl)phthalatedecreases expression, decreases methylation, increases abundance2
Acetaminophenincreases expression2
Arsenicincreases abundance, increases expression, affects expression, affects cotreatment2
Nickelincreases expression2
Valproic Aciddecreases expression, increases expression2
Particulate Matterdecreases expression, increases abundance, increases expression2
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
2,4,6-tribromophenoldecreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
glycidyl methacrylateincreases expression1
trichostatin Adecreases expression1
arseniteaffects binding, decreases reaction1
methylparabenincreases expression1
sulforaphaneincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
cobaltous chlorideincreases expression1
tetrabromobisphenol Aincreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
tri-o-cresyl phosphateincreases expression1
cupric oxideincreases expression1
hydroquinoneincreases expression1
brequinarincreases expression1

Cellosaurus cell lines

3 cell lines: 3 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D1N9Abcam K-562 HSPA13 KOCancer cell lineFemale
CVCL_D2JUAbcam Raji HSPA13 KOCancer cell lineMale
CVCL_UQ75Abcam Jurkat HSPA13 KOCancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.